J Korean Cancer Assoc.
1991 Dec;23(4):790-797.
Alterating combination chemotherapy of cyclophosphamide, adriamycin, and vincristine(CAV) with etoposide and cisplatin(EP) in small cell lung cancer
Abstract
- No abstract available.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Alternating non-cross-resistant chemotherapy with CAV(cyclophosphamide, adriamycin, vincristine) and EP(etoposide, cisplatin) in small cell lung cancer
- Combination chemotherapy with cyclophosphamide, vincristine, cisplatin, and etoposide(COPE) combined with radiotherapy for small cell lung cancer
- Effect Of Vpp/Cav Alternating Chemotherapy Versus Carboplatin/Etoposide(Ce) Chemotherapy For Extensive Stage Small Cell Lung Cancer
- A Phase II Trial of Combination Chemotherapy with Cisplatin & Etoposide in Small Cell Lung Cancer
- Enhancement of Cytotoxicity by the Combination of Anticancer Drugs in Human Lung Adenocarcinoma Cell Line (PC-14)
